Since Cheang et al. reported that Ki67 effectively distinguishes Luminal A from Luminal B subtypes [32,33], the critical value of Ki67 in BC has been intensively explored through clinical research but is still under debate. This evidence concerns the gene MKI67 and breast cancer.